News
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
Post-COVID data show that circulatory claims have increased by nearly 60%, while neoplasms remain the leading source of ...
10dOpinion
The Well News on MSNInternational Pricing Puts People With Chronic Diseases at RiskA recent White House executive order could make it harder for millions of Americans to access their lifesaving medications.
Its causes are too numerous to list. It can cripple a person’s body, state of mind, bank account, quality of life, and job ...
Patients with CSU have a higher burden than patients with CIndU, including on quality of life, economic effect, and knowledge about treatment.
Health-care companies rose as deal activity offset more health-insurance controversy. Merck struck a roughly $10 billion deal to buy Verona Pharma, bolstering its lineup with the chronic obstructive ...
Minister of Health and Wellness Dr. Michael Darville said yesterday that a bill that would integrate the prescription drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results